Gelatin-based delivery systems for cancer gene therapy

References

• Alain Rolland SMS. (2003). Pharmaceutical Gene Delivery Systems. New York: Marcel Dekker.
   Google Scholar
• Bhindi R, Fahmy RG, Lowe HC, Chesterman CN, Dass CR, Cairns MJ, Saravolac EG, Sun LQ, Khachigian LM. (2007). Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies. Am J Pathol, 171(4), 1079–1088.
   PubMed Web of Science ®Google Scholar
• Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Hearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF. (1995). T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science, 270(5235), 475–480.
   PubMed Web of Science ®Google Scholar
• Brown MD, Schatzlein AG, Uchegbu IF. (2001). Gene delivery with synthetic (non viral) carriers. Int J Pharm, 229(1-2), 1–21.
   PubMed Web of Science ®Google Scholar
• Coester CJ, Langer K, van Briesen H, Kreuter J. (2000). Gelatin nanoparticles by two step desolvation—a new preparation method, surface modifications and cell uptake. J Microencapsul, 17(2), 187–193.
   PubMed Web of Science ®Google Scholar
• Dang JM, Leong KW. (2006). Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev, 58(4), 487–499.
   PubMed Web of Science ®Google Scholar
• Davis ME. (2002). Non-viral gene delivery systems. Curr Opin Biotechnol, 13(2), 128–131.
   PubMed Web of Science ®Google Scholar
• Digenis GA, Gold TB, Shah VP. (1994). Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J Pharm Sci, 83(7), 915–921.
   PubMed Web of Science ®Google Scholar
• Domb AJ, Kost J, Wiseman DM. (1997). Handbook of Biodegradable Polymers. Boca Raton, FL: CRC Press, Taylor & Francis Group.
   Google Scholar
• Edelstein ML, Abedi MR, Wixon J, Edelstein RM. (2004). Gene therapy clinical trials worldwide 1989–2004—an overview. J Gene Med, 6(6), 597–602.
   PubMed Web of Science ®Google Scholar
• Fukunaka Y, Iwanaga K, Morimoto K, Kakemi M, Tabata Y. (2002). Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J Control Release, 80(1-3), 333–343.
   PubMed Web of Science ®Google Scholar
• Gao X, Huang L. (1996). Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry, 35(3), 1027–1036.
   PubMed Web of Science ®Google Scholar
• Gene Therapy Clinical Trials Worldwide. (2009). http://www.wiley.co.uk/genetherapy/clinical/. Last accessed May 4, 2009.
   Google Scholar
• Gómez-Estaca J, Monteroa P, Fernández-Martín F, Gómez-Guillén MC. (2009). Physico-chemical and film-forming properties of bovine-hide and tuna-skin gelatin: a comparative study. J Food Process Eng, 90, 480–486.
   Web of Science ®Google Scholar
• Gorecki DC. (2001). Prospects and problems of gene therapy: an update. Expert Opin Emerg Drugs, 6(2), 187–198.
   PubMedGoogle Scholar
• Habib NA. (2000). Cancer Gene Therapy: Past Achievements and Future Challenges. New York: Kluwer Academic Publishers.
   Google Scholar
• Hunter AC. (2006). Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev, 58(14), 1523–1531.
   PubMed Web of Science ®Google Scholar
• Igor Galaev BM. (2008). Smart Polymers Applications in Biotechnology and Biomedicine. Boca Raton, FL: CRC Press, Taylor & Francis Group.
   Google Scholar
• Imeson A. (1997). Thickening and Gelling Agents for Food. 2nd ed. London: Blackie Academic and Professional.
   Google Scholar
• Isobe H, Sugiyama S, Fukui Ki, Iwasawa Y, Nakamura E. (2001). Atomic force microscope studies on condensation of plasmid DNA with functionalized fullerenes. This research was supported by Grant-in-Aid for Specially Promoted Research from Ministry of Education, Culture, Sports, Science, and Technology. Angew Chem Int Ed Engl, 40(18), 3364–3367.
   PubMed Web of Science ®Google Scholar
• Karim AA, Bhat R. (2009). Fish gelatin: properties, challenges, and prospects as an alternative to mammalian gelatins. Food Hydrocolloids, 23, 563–576.
   Web of Science ®Google Scholar
• Kaul G, Amiji M. (2002). Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res, 19(7), 1061–1067.
   PubMed Web of Science ®Google Scholar
• Kommareddy S, Amiji M. (2007). Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors. Cancer Gene Ther, 14(5), 488–498.
   PubMed Web of Science ®Google Scholar
• Kuo PY, Saltzman WM. (1996). Novel systems for controlled delivery of macromolecules. Crit Rev Eukaryot Gene Expr, 6(1), 59–73.
   PubMed Web of Science ®Google Scholar
• Kushibiki T, Matsumoto K, Nakamura T, Tabata Y. (2004a). Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Gene Ther, 11(15), 1205–1214.
   PubMed Web of Science ®Google Scholar
• Kushibiki T, Matsumoto K, Nakamura T, Tabata Y. (2004b). Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres. Pharm Res, 21(7), 1109–1118.
   PubMed Web of Science ®Google Scholar
• Leaf Huang M-CH, Wagner E. (2005). Non-Viral Vectors for Gene Therapy. Vol. 1, 2nd ed. San Diego, CA: Elsevier Inc.
   Google Scholar
• Mansouri S, Lavigne P, Corsi K, Benderdour M, Beaumont E, Fernandes JC. (2004). Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm, 57(1), 1–8.
   PubMed Web of Science ®Google Scholar
• Marty JJ, Oppenheimer RC, Speiser P. (1978). Nanoparticles—a new colloidal drug delivery system. Pharm Acta Helv, 53(1), 17–23.
   PubMedGoogle Scholar
• Matsumoto G, Kushibiki T, Kinoshita Y, Lee U, Omi Y, Kubota E, Tabata Y. (2006). Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma. Cancer Sci, 97(4), 313–321.
   PubMed Web of Science ®Google Scholar
• McTaggart S, Al-Rubeai M. (2002). Retroviral vectors for human gene delivery. Biotechnol Adv, 20(1), 1–31.
   PubMed Web of Science ®Google Scholar
• Mumper RJ, Duguid JG, Anwer K, Barron MK, Nitta H, Rolland AP. (1996). Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharm Res, 13(5), 701–709.
   PubMed Web of Science ®Google Scholar
• Park BH, Lee JH, Jeong JS, Rha SH, Kim SE, Kim JS, Kim JM, Hwang TH. (2005). Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytes. Cancer Gene Ther, 12(2), 116–121.
   PubMed Web of Science ®Google Scholar
• Park TG, Jeong JH, Kim SW. (2006). Current status of polymeric gene delivery systems. Adv Drug Deliv Rev, 58(4), 467–486.
   PubMed Web of Science ®Google Scholar
• Patil SD, Rhodes DG, Burgess DJ. (2005). DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J, 7(1), E61–E77.
   PubMed Web of Science ®Google Scholar
• Scheffel U, Rhodes BA, Natarajan TK, Wagner HN Jr. (1972). Albumin microspheres for study of the reticuloendothelial system. J Nucl Med, 13(7), 498–503.
   PubMed Web of Science ®Google Scholar
• Schmidt-Wolf GD, Schmidt-Wolf IG. (2003). Non-viral and hybrid vectors in human gene therapy: an update. Trends Mol Med, 9(2), 67–72.
   PubMed Web of Science ®Google Scholar
• Swarbrick J. (2007). Encyclopedia of Pharmaceutical Technology. 3rd ed. New York: Informa Healthcare USA, Inc.
   Google Scholar
• Tabata K, Watanabe M, Naruishi K, Edamura K, Satoh T, Yang G, Abdel Fattah E, Wang J, Goltsov A, Floryk D, Soni, SD, Kadmon D, Thompson TC. (2008). Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer. Prostate Cancer Prostatic Dis, [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Taira K, Kataoka, K, Niidome T. (eds.). (2005). Non-Viral Gene Therapy Gene Design and Delivery. Tokyo: Springer-Verlag Tokyo.
   Google Scholar
• Tomioka A, Tanaka M, De Velasco MA, Anai S, Takada S, Kushibiki T, Tabata Y, Rosser CJ, Uemura H, Hirao Y. (2008). Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation. Mol Cancer Ther, 7(7), 1864–1870.
   PubMed Web of Science ®Google Scholar
• Truong-Le VL, August JT, Leong KW. (1998). Controlled gene delivery by DNA-gelatin nanospheres. Hum Gene Ther, 9(12), 1709–1717.
   PubMed Web of Science ®Google Scholar
• Truong-Le VL, Walsh SM, Schweibert E, Mao HQ, Guggino WB, August JT, Leong KW. (1999). Gene transfer by DNA-gelatin nanospheres. Arch Biochem Biophys, 361(1), 47–56.
   PubMed Web of Science ®Google Scholar
• United States Pharmacopeia (USP 31, NF 26). (2008). Baltimore: Port City Press.
   Google Scholar
• Vorburger SA, Hunt KK. (2002). Adenoviral gene therapy. Oncologist, 7(1), 46–59.
   PubMed Web of Science ®Google Scholar
• Weir B, Zhao X, Meyerson M. (2004). Somatic alterations in the human cancer genome. Cancer Cell, 6(5), 433–438.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Ikada Y, Tabata Y. (2001). Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed, 12(1), 77–88.
   PubMed Web of Science ®Google Scholar
• Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ. (1995). Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem, 270(32), 18997–19007.
   PubMed Web of Science ®Google Scholar
• Zhang X, Godbey WT. (2006). Viral vectors for gene delivery in tissue engineering. Adv Drug Deliv Rev, 58(4), 515–534.
   PubMed Web of Science ®Google Scholar
• Zwiorek K, Kloeckner J, Wagner E, Coester C. (2005). Gelatin nanoparticles as a new and simple gene delivery system. J Pharm Pharm Sci, 7(4), 22–28.
   PubMedGoogle Scholar